These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 21131914)

  • 1. Neuro-oncology: Genetic variation in pediatric and adult brain tumors.
    Brandes AA; Franceschi E
    Nat Rev Neurol; 2010 Dec; 6(12):653-4. PubMed ID: 21131914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review of the genomic landscape of common pediatric CNS tumors and how data sharing will continue to shape this landscape in the future.
    Kaneva K; Goldman S
    Mol Biol Rep; 2021 Nov; 48(11):7537-7544. PubMed ID: 34643931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in the molecular classification of pediatric brain tumors: a guide to the galaxy.
    Cacciotti C; Fleming A; Ramaswamy V
    J Pathol; 2020 Jul; 251(3):249-261. PubMed ID: 32391583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pediatric brain tumors: the era of molecular diagnostics, targeted and immune-based therapeutics, and a focus on long term neurologic sequelae.
    Plant-Fox AS; O'Halloran K; Goldman S
    Curr Probl Cancer; 2021 Aug; 45(4):100777. PubMed ID: 34303558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetics: a new tool for the study of genetic changes in brain tumors.
    Arnoldus EP; Wolters LB; Voormolen JH; van Duinen SG; Raap AK; van der Ploeg M; Peters AC
    J Neurosurg; 1992 Jun; 76(6):997-1003. PubMed ID: 1588436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting Laboratory Insights to Improve Outcomes of Pediatric Central Nervous System Tumors.
    Robinson GW; Witt H; Resnick A
    Am Soc Clin Oncol Educ Book; 2016; 35():e540-6. PubMed ID: 27249765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms and therapeutic targets in pediatric brain tumors.
    Liu KW; Pajtler KW; Worst BC; Pfister SM; Wechsler-Reya RJ
    Sci Signal; 2017 Mar; 10(470):. PubMed ID: 28292958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting brain cancer: advances in the molecular pathology of malignant glioma and medulloblastoma.
    Huse JT; Holland EC
    Nat Rev Cancer; 2010 May; 10(5):319-31. PubMed ID: 20414201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytogenetic landscape of paired neurospheres and traditional monolayer cultures in pediatric malignant brain tumors.
    Zhao X; Zhao YJ; Lin Q; Yu L; Liu Z; Lindsay H; Kogiso M; Rao P; Li XN; Lu X
    Neuro Oncol; 2015 Jul; 17(7):965-77. PubMed ID: 25537021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial gliomas: report of four families, with chromosome studies.
    Chadduck WM; Netsky MG
    Neurosurgery; 1982 Apr; 10(4):445-9. PubMed ID: 6285217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic alterations in glioma and medulloblastoma.
    Rasheed BK; Bigner SH
    Cancer Metastasis Rev; 1991 Dec; 10(4):289-99. PubMed ID: 1786630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances on Epigenetic Drugs for Pediatric Brain Tumors.
    Skouras P; Markouli M; Strepkos D; Piperi C
    Curr Neuropharmacol; 2023; 21(7):1519-1535. PubMed ID: 36154607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncogene amplification in pediatric brain tumors.
    Wasson JC; Saylors RL; Zeltzer P; Friedman HS; Bigner SH; Burger PC; Bigner DD; Look AT; Douglass EC; Brodeur GM
    Cancer Res; 1990 May; 50(10):2987-90. PubMed ID: 2334901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive high-resolution genomic profiling and cytogenetics of two pediatric and one adult medulloblastoma.
    Holland H; Xu LX; Ahnert P; Kirsten H; Koschny R; Bauer M; Schober R; Meixensberger J; Krupp W
    Pathol Res Pract; 2013 Sep; 209(9):541-7. PubMed ID: 23896263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chromosomal characteristics of neurogenic tumours in adults.
    Mark J
    Hereditas; 1971; 68(1):61-100. PubMed ID: 4376136
    [No Abstract]   [Full Text] [Related]  

  • 16. A molecular fingerprint for medulloblastoma.
    Lee Y; Miller HL; Jensen P; Hernan R; Connelly M; Wetmore C; Zindy F; Roussel MF; Curran T; Gilbertson RJ; McKinnon PJ
    Cancer Res; 2003 Sep; 63(17):5428-37. PubMed ID: 14500378
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant brain tumors: two steps forward.
    Puget S; Rutka JT
    Clin Neurosurg; 2007; 54():4-9. PubMed ID: 18504889
    [No Abstract]   [Full Text] [Related]  

  • 18. Class III beta-tubulin isotype: a key cytoskeletal protein at the crossroads of developmental neurobiology and tumor neuropathology.
    Katsetos CD; Legido A; Perentes E; Mörk SJ
    J Child Neurol; 2003 Dec; 18(12):851-66; discussion 867. PubMed ID: 14736079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Developmental origins and oncogenic pathways in malignant brain tumors.
    Lu QR; Qian L; Zhou X
    Wiley Interdiscip Rev Dev Biol; 2019 Jul; 8(4):e342. PubMed ID: 30945456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using mice to decipher the molecular genetics of brain tumors.
    Hesselager G; Holland EC
    Neurosurgery; 2003 Sep; 53(3):685-94; discussion 695. PubMed ID: 12943584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.